Preparing a neurology department for SARS-CoV-2 (COVID-19)
Genna Waldman, Richard Mayeux, Jan Claassen, Sachin Agarwal, Joshua Z. Willey, Emily E. Anderson, Patricia Punzalan, Ryan Lichtcsien, Michelle Bell, Serge Przedborski, Christina Ulane, Kirk Roberts, Olajide Williams, Andrew B. Lassman, Laura Lennihan, Kiran T. Thakur
Abstract
Beginning in December 2019, a novel coronavirus, SARS-CoV-2 (COVID-19), began spreading rapidly throughout China and now is a global pandemic, with cases reported in over 192 countries and territories worldwide. Clinically, COVID-19 ranges from a mild, self-limiting respiratory illness to severe progressive pneumonia and multiorgan failure. The first COVID-19 case was reported at the beginning of March in New York City (NYC), and now just 3 weeks later, NYC and its suburbs have over 5% of global cases. Worldwide, there is a rapid increase in the number of cases daily, including the number of patients requiring hospitalization and intensive care support.